Found: 167
Select item for more details and to access through your institution.
The Hari/Pasquini/Vesole Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1242
- By:
- Publication type:
- Article
Novel Agents in First-Line Therapy for Myeloma.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 12, p. 1551
- By:
- Publication type:
- Article
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00934-x
- By:
- Publication type:
- Article
Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework.
- Published in:
- American Health & Drug Benefits, 2015, v. 8, n. 4, p. 204
- By:
- Publication type:
- Article
The Role of Autologous Bone Marrow Transplantation in Acute Leukemiaa.
- Published in:
- Annals of the New York Academy of Sciences, 1987, v. 511, n. 1, p. 468, doi. 10.1111/j.1749-6632.1987.tb36278.x
- By:
- Publication type:
- Article
High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease.
- Published in:
- Annals of Internal Medicine, 1986, v. 104, n. 2, p. 163, doi. 10.7326/0003-4819-104-2-163
- By:
- Publication type:
- Article
Proteasome inhibition and its therapeutic potential in multiple myeloma.
- Published in:
- Biologics: Targets & Therapy, 2010, v. 4, p. 273, doi. 10.2147/BTT.S3419
- By:
- Publication type:
- Article
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy.
- Published in:
- 1985
- By:
- Publication type:
- journal article
High-dose chemotherapy with autologous bone marrow transplantation.
- Published in:
- Cancer (0008543X), 1984, v. 54, n. S1, p. 1216, doi. 10.1002/1097-0142(19840915)54:1+<1216::AID-CNCR2820541320>3.0.CO;2-E
- By:
- Publication type:
- Article
Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 93, doi. 10.1111/bjh.17131
- By:
- Publication type:
- Article
Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 4, p. e126, doi. 10.1111/bjh.16550
- By:
- Publication type:
- Article
Development of a prognostic model for overall survival in multiple myeloma using the Connect<sup>®</sup> MM Patient Registry.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 602, doi. 10.1111/bjh.16139
- By:
- Publication type:
- Article
Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 495, doi. 10.1111/bjh.15384
- By:
- Publication type:
- Article
Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 821, doi. 10.1111/bjh.15058
- By:
- Publication type:
- Article
A phase II trial of TBL‐12 sea cucumber extract in patients with untreated asymptomatic myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 296, doi. 10.1111/bjh.14314
- By:
- Publication type:
- Article
Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 884, doi. 10.1111/bjh.14014
- By:
- Publication type:
- Article
Trial designs and endpoints for immune therapies in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S35, doi. 10.1002/ajh.26753
- By:
- Publication type:
- Article
Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02616
- By:
- Publication type:
- Article
Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Essentials for Tailoring Multiple Myeloma Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 3, p. 5
- By:
- Publication type:
- Article
What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2369, doi. 10.3390/cancers15082369
- By:
- Publication type:
- Article
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5996, doi. 10.3390/cancers13235996
- By:
- Publication type:
- Article
Second bone marrow transplants for relapsed leukemia.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
- Published in:
- 1991
- By:
- Publication type:
- journal article
High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Multiple Myeloma: Biologic Understanding and Curative Outcome – Pushing the Envelope.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S2, doi. 10.3816/CLM.2009.s.008
- By:
- Publication type:
- Article
Expanding Our Mission: Clinical Lymphoma, Myeloma & Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 4, p. 266, doi. 10.3816/CLM.2009.n.054
- By:
- Publication type:
- Article
Multiple Myeloma: Biologic Understanding and Curative Outcome – Pushing the Envelope.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S2
- By:
- Publication type:
- Article
Upcoming International Myeloma Workshop Offers Opportunity for Review of Current Treatment Options and Consensus Recommendations.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 6, p. 330
- By:
- Publication type:
- Article
Treatment of Patients with Myeloma with Comorbid Conditions: Considerations for the Clinician.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, p. S149
- By:
- Publication type:
- Article
Progress in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 4, p. 202
- By:
- Publication type:
- Article
Association Between Renal Cell Carcinoma and Plasma Cell Dyscrasias: A Case Series of Six Patients.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 3, p. 188
- By:
- Publication type:
- Article
Highlights from: 49th Annual Meeting of the American Society of Hematology; Atlanta, GA; December 8-11, 2007.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 2, p. 77
- By:
- Publication type:
- Article
Highlights from: 49th Annual Meeting of the American Society of Hematology; Atlanta, GA; December 8-11, 2007.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 1, p. 13
- By:
- Publication type:
- Article
Current Standards for First-Line Therapy of Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S207
- By:
- Publication type:
- Article
Value of Serum Free Light Chain Testing for the Diagnosis and Monitoring of Monoclonal Gammopathies in Hematology.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 518
- By:
- Publication type:
- Article
Repeated Complete Responses with Bortezomib in a Heavily Pretreated Primary Refractory Patient with Light Chain Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 5, p. 373
- By:
- Publication type:
- Article
Bortezomib Dosing in Relapsed Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 101
- By:
- Publication type:
- Article
Engraftment Syndrome After Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 151
- By:
- Publication type:
- Article
The Role of Thalidomide in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 1, p. 26
- By:
- Publication type:
- Article
Highights From: 47th Annual Meeting of the American Society of Hematology, December 2005, Atlanta, GA.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 6, p. 448
- By:
- Publication type:
- Article
Connect MM Registry as a national reference for United States multiple myeloma patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 35, doi. 10.1002/cam4.2656
- By:
- Publication type:
- Article
The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 3, p. 500, doi. 10.1002/cam4.620
- By:
- Publication type:
- Article
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/2040620720987075
- By:
- Publication type:
- Article
Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Asymptomatic monoclonal gammopathies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Complete Remission Achieved With Single Agent CNTO 328, an Anti-IL-6 Monoclonal Antibody, in Relapsed and Refractory Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 333, doi. 10.1016/j.clml.2012.12.010
- By:
- Publication type:
- Article
A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 175, doi. 10.1016/j.clml.2012.09.010
- By:
- Publication type:
- Article